Connect with us
Information
About Us
Contact Us
Careers
Partnerships
Advertise With Us
Authors
Browse Topics
Events
Disclaimer
Privacy Policy
Australia
North America
World
Login
Investing News
Network
Your trusted source for investing success
North America
Australia
World
My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
Reports & Guides
Market Outlook Reports
Investing Guides
Resource
Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals
Tech
Life Science
phase 3 clinical trial
POPULAR ARTICLES
MacroGenics Presents Results from SOPHIA Study
Abeona Therapeutics to Initiate Phase 3 Clinical Trial of B-101
Ocugen Completes 50 Percent Enrollment in Phase 3 Clinical Trial
LATEST ARTICLES
Acasti Pharma Updates on TRILOGY 1 Phase 3 Trial
Pharmaceutical Investing
Avadel Pharma Reaches Enrollment Target in REST-ON Trial
Tonix Pharmaceuticals Begins Phase 3 RELIEF Study
Pharmaceutical Investing
Alnylam Gets FDA Nod for Rare Disease Drug
Pharmaceutical Investing
The Unspoken Potential of Rosacea Treatments
Ocular Therapeutix Doses First Patient in Phase 3 Clinical Trial
UroGen Reports Data From Two Studies
Abeona to Submit More Data to FDA Before Starting Phase 3 Trial
Ovid Therapeutics’ First Patient Randomized in Pivotal Phase 3 NEPTUNE Trial
Mesoblast and Grunenthal Partner on Lower Back Pain Cell Therapy
Pharmaceutical Investing
AstraZeneca’s Lupus Drug Finally Meets Endpoints in Phase 3 Trial
Pharmaceutical Investing
Investing in Phase 3 Clinical Trials
Latest News
Forte Minerals Provides Update on Planned Drill Program at Pucarini High-Sulfidation Gold Project
Bold Ventures Announces Non-Brokered Private Placement and First Tranche Closing
Major Finland Gold Transaction
Halcones Precious Metals Closes Final Tranche of Life Offering and Announces Non-Brokered Offering
World Copper Provides Update
More News
